Published in Health Business Week, September 15th, 2006
Revenue from continuing operations increased from the prior year by 11% to $2,582 million.
In line with the company's dividend policy, the directors have declared a fully franked final dividend of 3 cents per share payable on 8 September, taking the full year dividend payment to 9.25 cents (FY2005: 13.0 cents). Stephen Roche has been appointed chief executive officer and managing director of the company following the resignation...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.